Silver Book Fact

The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.

Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine. The Economic Burden of Major Adult Visual Disorders in the United States. Archives of Ophthalmology. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Archives of Ophthalmology
Publication Date
2006
Authors
Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • One-third of age-related macular degeneration (AMD) patients suffer from clinical depression.  
  • The cost of age-related macular degeneration (AMD) is projected to increase to $845 million per year over the next 15 years, simply due to the growth in the number of…  
  • Age-related eye diseases are the primary causes of vision impairment and blindness in the U.S.  
  • An estimated 1.75 million Americans age 40 and older have advanced age-related macular degeneration (AMD). Another 7.3 million are at substantial risk for vision loss from AMD.  
  • More than 2.1 million Americans age 80 and older have low vision or are blind– 23.7% of the 80 and older population.